Genistein inhibition of topoisomerase IIalpha expression participated by Sp1 and Sp3 in HeLa cell

Int J Mol Sci. 2009 Jul 22;10(7):3255-3268. doi: 10.3390/ijms10073255.

Abstract

Genistein (4', 5, 7-trihydroxyisoflavone) is an isoflavone compound obtained from plants that has potential applications in cancer therapy. However, the molecular mechanism of the action of genistein on cancer cell apoptosis is not well known. In this study, we investigated the effect of genistein on topoisomerase II-alpha (Topo IIalpha), an important protein involved in the processes of DNA replication and cell proliferation. The results revealed that inhibition of Topo IIalpha expression through the regulation of Specificity protein 1 and Specificity protein 3 may be one of the reasons for genistein's induction of HeLa cell apoptosis.

Keywords: genistein; specificity protein 1 (Sp1); specificity protein 3 (Sp3); topoisomerase II-α.

MeSH terms

  • Anticarcinogenic Agents / pharmacology*
  • Antigens, Neoplasm / genetics
  • Antigens, Neoplasm / metabolism*
  • Apoptosis / drug effects
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / metabolism*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Genistein / pharmacology*
  • HeLa Cells
  • Humans
  • Sp1 Transcription Factor / genetics
  • Sp1 Transcription Factor / metabolism
  • Sp3 Transcription Factor / genetics
  • Sp3 Transcription Factor / metabolism
  • Transcription, Genetic / drug effects

Substances

  • Anticarcinogenic Agents
  • Antigens, Neoplasm
  • DNA-Binding Proteins
  • Sp1 Transcription Factor
  • Sp3 Transcription Factor
  • Genistein
  • DNA Topoisomerases, Type II